Long-term follow-up for people previously treated with azer-cel
Part of Immune system & allergy clinical trials.
This study is for people who already received the experimental treatment azer-cel in a previous trial. It will follow you over the long term to see how you're doing and monitor any lasting effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the earlier TG-Azercel-101 study and received at least one dose of the treatment azer-cel.
- You must sign a consent form saying you agree to take part.
- You must be able to follow the study schedule and meet all its requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how people do over a longer period after receiving azer-cel in an Imugene trial. It helps doctors understand long-term safety and health outcomes, even if you are feeling well now.
This study is a long-term follow-up for people who have already received a cell or gene therapy in a previous AstraZeneca trial. It helps researchers monitor your health over time to make sure the therapy is safe and effective.
This trial tests an investigational cell therapy called Azer-cel for people with certain types of blood cancer (non-Hodgkin lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, or B-cell acute lymphoblastic leukemia) that has come back or not responded to previous treatments. The therapy uses your own immune cells that have been modified to find and attack cancer cells.
This study follows patients who have had gene-modified T-cell therapy to track their health over time. It does not test a new treatment but helps doctors understand long-term effects.
This study is a long-term follow-up for people who previously received a gene therapy treatment called zamtocabtagene autoleucel in a Miltenyi Biomedicine-sponsored clinical study. It helps researchers monitor your health over time after the treatment.
This study is for people who have already received a special kind of cell therapy that involved modifying their genes. The purpose is to keep track of their health over a longer period of time to see how they are doing after the treatment.
Hear when a new B-cell Mediated Autoimmune Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.